Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Elizabeth Allen

1PUBLICATIONS
5CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Apr 14, 2017
Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation.

Elizabeth Allen, Arnaud Jabouille, Lee B Rivera

Pageof 1

Frequent Collaborators

1 joint publications

Arnaud Jabouille

1 joint publications

Lee B Rivera

1 joint publications

Rindert Missiaen

1 joint publications

Iacovos P Michael

1 joint publications

Gabriele Bergers

Frequent Collaborators

1 joint publications

Arnaud Jabouille

1 joint publications

Lee B Rivera

1 joint publications

Rindert Missiaen

1 joint publications

Iacovos P Michael

Top Related Videos

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

See more related videos

Top Related Videos

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

See more related videos